A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.

Blood-forming stem cells play a role in immune tolerance and acceptance of organ transplants, Vanderbilt researchers have discovered.

Research achievement was recognized recently during last week’s Diabetes Day at the Student Life Center.

The REACH study is offering Vanderbilt University Medical Center (VUMC) primary care patients with type 2 diabetes an opportunity to more easily track medication adherence, monitor A1C results, and make healthy lifestyle choices via text messaging.

Lengthening sleep duration and reducing sleep disturbances in children with type 1 diabetes may improve diabetes outcomes and reduce parental stress.

Medical studies have established that people with type 2 diabetes are more susceptible to fractures, but the biological process that weakens their bones is not understood.

A visionary $6 million gift to Vanderbilt from the Eskind family ensures that the Eskind Biomedical Library will support the next generation of scientists, physicians, students and patients.